A novel series of poly(10‐hexyl‐phenothiazine‐ S,S ‐dioxide‐3,7‐diyl) and poly(9,9′‐dioctyl‐fluorene‐2,7‐diyl‐ alt ‐10‐hexyl‐3,7‐phenothiazine‐ S,S ‐dioxide) (PFPTZ‐SS) compounds were synthesized through Ni(0)‐mediated Yamamoto polymerization and Pd(II)‐catalyzed Suzuki polymerization. The synthesized polymers were characterized by 1 H NMR spectroscopy and elemental analysis and showed higher glass transition temperatures than that of pristine polyfluorene. In terms of photoluminescence (PL), the PFPTZ‐SS compounds were highly fluorescent with bright blue emissions in the solid state. Light‐emitting devices were fabricated with these polymers in an indium tin oxide/poly(3,4‐ethylene dioxythiophene):poly(styrene sulfonate)/polymer/Ca/Al configuration. The electroluminescence (EL) of the copolymers differed from the PL characteristics: the EL device exhibited a redshifted greenish‐blue emission in contrast to the blue emission observed in the PL. Additionally, this unique phenothiazine‐ S,S ‐dioxide property, triggered by the introduction of an electron‐deficient SO 2 unit into the electron‐rich phenothiazine, gave rise to improvements in the brightness, maximum luminescence intensity, and quantum efficiency of the EL devices fabricated with PFPTZ‐SS.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: